Implementation of global antimicrobial resistance surveillance system (GLASS) in patients with bacteriuria

Sirijatuphat, Rujipas; Pongsuttiyakorn, Suchada; Supapueng, Orawan; Kiratisin, Pattarachai; Thamlikitkul, Visanu

doi:10.1016/j.jgar.2019.11.009

Cited by 16 publications

(15 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, integrating antimicrobial resistance monitoring with COVID-19 surveillance through a close collaboration between the pre-existing surveillance networks seems more than warranted 142 . To date, the use of smartphones and specific smartphone applications for surveillance has not advanced much, mainly owing to ethical objections that were raised 143 .…”

Section: Laboratory Medicinementioning

confidence: 99%

Considerations for diagnostic COVID-19 tests

et al. 2020

View full text Add to dashboard Cite

During the early phase of the coronavirus disease 2019 (COVID-19) pandemic, design, development, validation, verification and implementation of diagnostic tests were actively addressed by a large number of diagnostic test manufacturers. Hundreds of molecular tests and immunoassays were rapidly developed, albeit many still await clinical validation and formal approval. In this Review, we summarize the crucial role of diagnostic tests during the first global wave of COVID-19. We explore the technical and implementation problems encountered during this early phase in the pandemic, and try to define future directions for the progressive and better use of (syndromic) diagnostics during a possible resurgence of COVID-19 in future global waves or regional outbreaks. Continuous global improvement in diagnostic test preparedness is essential for more rapid detection of patients, possibly at the point of care, and for optimized prevention and treatment, in both industrialized countries and low-resource settings.

show abstract

Section: Laboratory Medicinementioning

confidence: 99%

Considerations for diagnostic COVID-19 tests

et al. 2020

View full text Add to dashboard Cite

show abstract

“…The principle of “deescalation” was adopted in antibiotic administration, stressing “early use, early stop” and “perioperative application.” Antibiotics were applied to wounds or administered systemically when they could not be applied to burn wounds. Similar strategies have been followed in several guidelines [ 19 – 21 ].…”

Section: Discussionmentioning

confidence: 99%

Urine Culture in Hospitalized Patients during 2014-2018: An Analysis on Pathogen Distribution and Drug Sensitivity

et al. 2021

View full text Add to dashboard Cite

Objective. We sought to analyze the distribution and antibiotic sensitivity of pathogens in hospitalized patients and to provide a scientific reference for the rational application of antibiotics. Methods. From January 2014 to December 2018, urine cultures from patients in our hospital were collected and analyzed retrospectively for the presence, distribution, and drug sensitivity of pathogens. Results. A total of 42,854 midstream urine cultures were collected from which 11,891 (27.75%) pathogens were isolated, including 8101 (68.13%) strains of gram-negative bacteria, 2580 (21.69%) strains of gram-positive bacteria, and 1210 (10.18%) strains of fungi. Escherichia coli and Enterococci were the most common species of gram-negative and gram-positive bacteria, respectively. Drug sensitivity varied among different pathogens. Clear drug resistance was observed in bacteria, while fungus exhibited relatively lower resistance. Conclusion. Pathogens responsible for urinary tract infections in hospitalized patients are diversiform and display resistance to some antibiotics. Drug resistance monitoring should be enhanced to optimize antimicrobial therapy.

show abstract

“…8 We did not include vancomycin as part of the empirical therapy in order to avoid the possibility of developing vancomycin-resistant S. aureus, 9 as recommended by the global antimicrobial resistance surveillance system (GLASS) report. 10 On the basis of the Infectious Diseases Society of America (IDSA) guidelines 4 for the diagnosis of sepsis and CRBSI, two BC sets for aerobic and anaerobic bacteria (BD Bactec TM PLUS/F Aerobic and Anaerobic medium, Becton Dickinson Diagnostics, Sparks, MD) were filled with 8-12 mL of blood that was collected from the HD circuit and from a peripheral vein, respectively. When peripheral vein sampling was not feasible, the sample was taken from the venous catheter hub.…”

Section: Methodsmentioning

confidence: 99%

High success rate in salvage of catheter-related bloodstream infections due to Staphylococcus aureus, on behalf of project group of Italian society of nephrology

et al. 2019

View full text Add to dashboard Cite

Background: Catheter-related bloodstream infections caused by Staphylococcus aureus represent one of the most fearful infections in chronic haemodialysis patients with tunnelled central venous catheters. Current guidelines suggest prompt catheter removal in patients with positive blood cultures for S. aureus. This manoeuvre requires inserting a new catheter into the same vein or another one and is not without its risks. Methods: A protocol based on early, prompt diagnosis and treatment has been utilized in our renal unit since 2012 in an attempt to salvage infected tunnelled central venous catheters. We prospectively observed 247 tunnelled central venous catheters in 173 haemodialysis patients involving 167,511 catheter days. Results: We identified 113 catheter-related bloodstream infections (0.67 episodes per 1000 days/tunnelled central venous catheter). Forty were caused by S. aureus, including 19 by methicillin-resistant S. aureus (79% saved) and 21 by methicillin-sensitive S. aureus (90% saved), of which 34 (85%) were treated successfully. Eight recurrences occurred and six (75%) were successfully treated. A greater than 12 h time to blood culture positivity for S. aureus was a good prognostic index for successful therapy and tunnelled central venous catheter rescue. Conclusion: Our data lead us to believe that it is possible to successfully treat catheter-related bloodstream infection caused by S. aureus and to avoid removing the tunnelled central venous catheter in many more cases than what has been reported in the literature. On the third day, it is mandatory to decide whether to replace the tunnelled central venous catheter or to carry on with antibiotic therapy. Apyrexia and amelioration of laboratory parameters suggest continuing systemic and antibiotic lock therapy for no less than 4 weeks, otherwise, tunnelled central venous catheter removal is recommended.

show abstract

Implementation of global antimicrobial resistance surveillance system (GLASS) in patients with bacteriuria

Cited by 16 publications

References 11 publications

Considerations for diagnostic COVID-19 tests

Considerations for diagnostic COVID-19 tests

Urine Culture in Hospitalized Patients during 2014-2018: An Analysis on Pathogen Distribution and Drug Sensitivity

High success rate in salvage of catheter-related bloodstream infections due to Staphylococcus aureus, on behalf of project group of Italian society of nephrology

Contact Info

Product

Resources

About